308 related articles for article (PubMed ID: 35573689)
1. Differential Effects of APOE Genotype on MicroRNA Cargo of Cerebrospinal Fluid Extracellular Vesicles in Females With Alzheimer's Disease Compared to Males.
Sandau US; McFarland TJ; Smith SJ; Galasko DR; Quinn JF; Saugstad JA
Front Cell Dev Biol; 2022; 10():864022. PubMed ID: 35573689
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.
Lusardi TA; Phillips JI; Wiedrick JT; Harrington CA; Lind B; Lapidus JA; Quinn JF; Saugstad JA
J Alzheimers Dis; 2017; 55(3):1223-1233. PubMed ID: 27814298
[TBL] [Abstract][Full Text] [Related]
3. Validation of MicroRNA Biomarkers for Alzheimer's Disease in Human Cerebrospinal Fluid.
Wiedrick JT; Phillips JI; Lusardi TA; McFarland TJ; Lind B; Sandau US; Harrington CA; Lapidus JA; Galasko DR; Quinn JF; Saugstad JA
J Alzheimers Dis; 2019; 67(3):875-891. PubMed ID: 30689565
[TBL] [Abstract][Full Text] [Related]
4. Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS).
Saunders TS; Jenkins N; Blennow K; Ritchie C; Muniz-Terrera G
EBioMedicine; 2022 Sep; 83():104241. PubMed ID: 36041266
[TBL] [Abstract][Full Text] [Related]
5. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
6. The role of microRNAs in understanding sex-based differences in Alzheimer's disease.
Llera-Oyola J; Carceller H; Andreu Z; Hidalgo MR; Soler-Sáez I; Gordillo F; Gómez-Cabañes B; Roson B; de la Iglesia-Vayá M; Mancuso R; Guerini FR; Mizokami A; García-García F
Biol Sex Differ; 2024 Jan; 15(1):13. PubMed ID: 38297404
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with the APOE4 genotype.
Motta C; Assogna M; Bonomi CG; Mascolo AP; De Lucia V; Semprini R; Mercuri NB; Koch G; Martorana A
Eur J Neurol; 2021 Dec; 28(12):3965-3971. PubMed ID: 34309155
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in Extracellular Vesicles of Alzheimer's Disease.
Li W; Zheng Y
Cells; 2023 May; 12(10):. PubMed ID: 37408212
[TBL] [Abstract][Full Text] [Related]
10. miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study.
Sørensen SS; Nygaard AB; Christensen T
Transl Neurodegener; 2016; 5():6. PubMed ID: 26981236
[TBL] [Abstract][Full Text] [Related]
11. APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer's disease and age-matched non-demented brains.
Ojo JO; Reed JM; Crynen G; Vallabhaneni P; Evans J; Shackleton B; Eisenbaum M; Ringland C; Edsell A; Mullan M; Crawford F; Bachmeier C
Mol Brain; 2021 Jul; 14(1):110. PubMed ID: 34238312
[TBL] [Abstract][Full Text] [Related]
12. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
[TBL] [Abstract][Full Text] [Related]
13. Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.
Johansson P; Almqvist EG; Bjerke M; Wallin A; Johansson JO; Andreasson U; Blennow K; Zetterberg H; Svensson J
J Alzheimers Dis; 2017; 59(3):1017-1026. PubMed ID: 28697566
[TBL] [Abstract][Full Text] [Related]
14. Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease.
Giannisis A; Al-Grety A; Carlsson H; Patra K; Twohig D; Sando SB; Lauridsen C; Berge G; Grøntvedt GR; Bråthen G; White LR; Kultima K; Nielsen HM
Alzheimers Res Ther; 2022 Aug; 14(1):115. PubMed ID: 36002891
[TBL] [Abstract][Full Text] [Related]
15. Profile of Pathogenic Proteins and MicroRNAs in Plasma-derived Extracellular Vesicles in Alzheimer's Disease: A Pilot Study.
Li F; Xie XY; Sui XF; Wang P; Chen Z; Zhang JB
Neuroscience; 2020 Apr; 432():240-246. PubMed ID: 32135232
[TBL] [Abstract][Full Text] [Related]
16. Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment.
Cho H; Kim YE; Chae W; Kim KW; Kim JW; Kim HJ; Na DL; Ki CS; Seo SW
Sci Rep; 2020 Aug; 10(1):13365. PubMed ID: 32770103
[TBL] [Abstract][Full Text] [Related]
17. Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease.
Mosconi L; Nacmias B; Sorbi S; De Cristofaro MT; Fayazz M; Tedde A; Bracco L; Herholz K; Pupi A
J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):370-6. PubMed ID: 14966149
[TBL] [Abstract][Full Text] [Related]
18. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients.
Lennol MP; Sánchez-Domínguez I; Cuchillo-Ibañez I; Camporesi E; Brinkmalm G; Alcolea D; Fortea J; Lleó A; Soria G; Aguado F; Zetterberg H; Blennow K; Sáez-Valero J
Alzheimers Res Ther; 2022 Nov; 14(1):161. PubMed ID: 36324176
[TBL] [Abstract][Full Text] [Related]
20. The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease.
Yassine HN; Rawat V; Mack WJ; Quinn JF; Yurko-Mauro K; Bailey-Hall E; Aisen PS; Chui HC; Schneider LS
Alzheimers Res Ther; 2016 Jun; 8():25. PubMed ID: 27358067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
